BioSpace News Archive

Entire EZ Shot 3 Plus Line-Up Now Cleared for Fine Needle Biopsy

CORRECTION...by Primex Pharmaceuticals

According to the data compiled by Energias Market Research, the global medical cannabis market is expected to increase from USD 8.28 Billion in 2017 to USD 28.07 Billion in 2024 and at a CAGR of 19.1% from 2018 to 2024.

Welltok, a data-driven, enterprise SaaS company that delivers the industry’s leading consumer health activation platform, has been named to the Forbes 2018 Cloud 100 for the second consecutive year.

A new report released today on Medicare Part D found the program is as popular and robust as ever, but faces challenges that could result in increased costs and limited access for millions of beneficiaries.

With an expanding portfolio of breakthrough innovations, FACIT is committed to supporting Ontario entrepreneurs through the latest round of its Prospects Oncology Fund. FACIT has selected three novel cancer therapeutic discoveries to receive early-stage capital - biotechnology start-up Talon Pharmaceuticals (“Talon”), the Drug Discovery team at the Ontario Institute for Cancer Research (“OICR”) and CCRM.

Patients at Nationwide Children’s Hospital, one of America’s largest not-for-profit freestanding pediatric health care systems, now have the latest enhancement for intravenous (IV) therapy with the installation of the ivWatch Model 400.

Compulink Healthcare Solutions will demonstrate the latest enhancements to Dermatology Advantage™ at this week’s 2018 CalDerm Symposium.

Directed by an Academy Award® winning filmmaker in the documentary short subject category, “Something So Rare” chronicles the lives of four people living with MPNs, rare blood cancers

New Statement Calls for Greater Support for Science Educators to Teach Evidence-based Science